Maia Szalavitz is the author, most recently, of Unbroken Brain: A Revolutionary New Way of Understanding Addiction, which will be released in paperback in May. She has written about neuroscience and addiction for nearly 30 years for publications ranging from the New York Times and Washington Post to TIME and Scientific American.
Maia Szalavitz
Neuroscience Journalist
Freelance
From this contributor
Autism’s hidden habit
Conventional wisdom holds that people with autism don't get hooked on alcohol or other drugs, but new evidence suggests otherwise.
New tests extend prospects for ‘reading the mind in the eyes’
Researchers have revamped a screen for ‘mind blindness’ — an impaired understanding of others’ intentions and perspectives — which is a key deficit in autism. The revised test may shed light on how autism develops.
New tests extend prospects for ‘reading the mind in the eyes’
By
Maia Szalavitz
8 April 2014 | 3 min read
‘Resting’ autism brains still hum with activity
Even at rest, the brains of people with autism manage more information than those of their peers, according to a new study that may provide support for the so-called ‘intense world’ theory of autism.
‘Resting’ autism brains still hum with activity
By
Maia Szalavitz
21 February 2014 | 3 min read
First 1,000 days of life could hold keys to autism
Autism researchers have high hopes for a new project called the First 1,000 Days of Life, which aims to follow 5,000 women and their babies from pregnancy through two years after birth.
First 1,000 days of life could hold keys to autism
By
Maia Szalavitz
17 February 2014 | 4 min read
Long neglected, severe cases of autism get some attention
A large new project aims to link specialized psychiatric units across the U.S. to investigate the causes and best treatment for autism’s most severe and challenging cases.
Long neglected, severe cases of autism get some attention
By
Maia Szalavitz
19 December 2013 | 5 min read
Explore more from The Transmitter
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
By
The Transmitter
21 November 2025 | 6 min read
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
By
Charles Q. Choi
20 November 2025 | 5 min read
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
By
Paul Middlebrooks
19 November 2025 | 1 min read